Kaiser Health News: Drug Trade Group Quietly Spends ‘Dark Money’ To Sway Policy And Voters
PhRMA was one of AAN’s biggest donors the previous year, giving it $6.1 million, federal regulatory findings show
PhRMA was one of AAN’s biggest donors the previous year, giving it $6.1 million, federal regulatory findings show
Though drug makers continue to raise prices out of proportion to increases in value, PBMs are doing their job by keeping drug costs down
Even including discounts, however, the company’s net profit margin for 2017 was 34 percent, its highest since at least 2000, when it was half that high.
PCMA said the changes wouldn’t be as disruptive as others argued, and highlighted several classes of drugs
Pharmaceutical companies gave at least $116 million to patient advocacy groups in a single year
Unlocking an Affordable Future: Key #2 Support and Equip Clinicians SUPPORT AND EQUIP CLINICIANS WITH TOOLS AND DATA TO SERVE PATIENTS OPTIMALLY Physicians, pharmacists, and other health care providers are valued employees within pharmacy benefit companies and esteemed healthcare partners outside
JC Scott speaks with Doug Long, Vice President of Industry Relations at IQVIA, about the impact of COVID-19 on the pharmaceutical market. IQVIA is a world leader in using data, technology, advanced analytics and expertise to help customers drive healthcare
Agnita Kote Chief Financial Officer Agnita Kote is the Chief Financial Officer for PCMA. She provides strategic financial planning and management of PCMA’s financial affairs. Agnita has more than a decade of finance and accounting experience. Prior to joining PCMA, she
(Washington, D.C.) — Today, representative organizations of America’s pharmaceutical supply and payment chain, including prescription and over-the-counter brand and generic manufacturers; wholesalers; retail, specialty, and managed care, pharmacies; health insurance providers and other payers; pharmacists in hospitals and health systems; and
©2024 PCMA. All Rights Reserved.